company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-459851000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-459851000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32196000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,63634000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,137783000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-226238000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-226482000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-32180000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-755422000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,427648000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-696000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-360650000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-360650000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-19997000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,278607000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,362128000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,620738000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,620738000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-154000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33452000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 16:37:47+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,6676000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-158644000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-158644000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8383000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3125000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,34053000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10756000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-102327000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-102327000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7578000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-811934000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,271023000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,712000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-547777000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-547777000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,27731000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,511025000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,538494000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,538664000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1035000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-112475000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-642178000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-642178000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30107000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3125000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,122161000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,59199000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-427586000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-427586000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23496000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-87422000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1186701000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,788263000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,624000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-508732000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-508732000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,150033000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,849235000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,999006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,999006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5145000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,57543000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,2009-01-01,2009-12-31,2012-02-22 17:08:51+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,10248000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-149565000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-149565000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6815000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,21565000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,99550000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21635000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21635000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4753000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-124052000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,171783000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-453000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,42525000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,42525000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,122217000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8376000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,130593000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,130593000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1299000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,150184000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3,2009-07-01,2009-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3420000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-483534000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-483534000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21724000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,88108000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,48443000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-325259000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-325259000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15918000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-87422000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-374767000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,517240000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-88000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,39045000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,39045000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,122302000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,338210000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,460512000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,460342000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4110000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,170018000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 16:53:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,10248000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-171297000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-171297000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7745000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,41040000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4447000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-118065000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-118065000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4586000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-250715000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,171451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,193000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-83657000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-83657000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11081000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2609000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2,2009-04-01,2009-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-193250000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-333969000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-333969000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14909000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,66543000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-51107000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-303624000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-303624000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11165000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-87422000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-250715000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,345457000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,365000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3480000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3480000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,85000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,329834000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,329919000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,329749000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2811000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19834000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-03 16:41:27+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,6828000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-162672000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-162672000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7164000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25503000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-55554000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-185559000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-185559000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6579000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-87422000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,174006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,172000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,80177000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,80177000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,318668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,318668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,318668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-202000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,213084000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,Q1,2009-01-01,2009-03-31,2010-05-03 16:33:34+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,6828000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-180392000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-180392000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8205000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3568000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,32034000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-29518000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-166103000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-166103000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14428000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-460189000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,305015000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-93000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-169695000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-169695000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9447000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9447000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9447000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-353000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-326704000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-754626000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-754626000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30459000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,13589000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,138913000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-63777000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-635442000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-635442000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-38054000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1234719000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1284806000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4732000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7301000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7301000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,391667000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,33434000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,425057000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,425057000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-377000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-203461000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,761000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,2010-01-01,2010-12-31,2013-03-01 16:01:47+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-732878000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-732878000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30637000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,13146000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,140932000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-23503000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-571666000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-571666000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-31204000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1586464000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1250814000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3927000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-370781000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-370781000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,419398000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,535012000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,954104000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,954274000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1059000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10768000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3TTM,2009-10-01,2010-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,761000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-208957000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-208957000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6758000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,30855000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3903000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-163990000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-163990000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10830000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-453278000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,461650000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,44000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,391645000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6850000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,398451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,398495000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,202000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,232293000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-574234000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-574234000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,22254000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,10021000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,106879000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-34259000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-469339000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-469339000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23626000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-774530000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,979791000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4639000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,176996000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,176996000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,391667000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,23987000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,415610000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,415610000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-24000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,123243000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-03 17:16:53+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,761000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-673486000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-673486000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30694000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9695000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,131642000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,72144000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-429311000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-429311000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25127000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1257238000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,960947000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4424000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-325842000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-325842000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,149970000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,536538000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,686246000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,686372000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2560000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-71341000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2TTM,2009-07-01,2010-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4181000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-200006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-200006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7912000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3339000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,53768000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,26100000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-108887000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-108887000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9686000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-279230000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,333867000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4303000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,40648000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,40648000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,22000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,22000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9473000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9517000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9473000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-173000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-58939000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-365277000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-365277000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15496000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6570000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,76024000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-38162000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-305349000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-305349000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12796000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-321252000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,518141000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4683000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,179410000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,179410000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,22000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17137000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,17159000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,17115000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-226000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-109050000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-09 16:13:29+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,761000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-644777000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-644777000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30527000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6356000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,118914000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,50491000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-438489000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-438489000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20027000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1228723000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,798531000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,72000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-450147000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-450147000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-22000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,150033000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,538231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,687980000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,687980000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4996000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-205652000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1TTM,2009-04-01,2010-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4181000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-165271000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-165271000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7584000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22256000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-64262000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-196462000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-196462000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3110000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42022000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,184274000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-380000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,138762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,138762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-22000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7664000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7642000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7642000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-53000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-50111000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:18:42+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,761000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,188141000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,188141000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9724000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6553000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,31456000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,267789000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,503663000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,503663000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9329000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-470456000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,91618000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,391000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-387776000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-387776000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-105000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16120000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-94100000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-182980000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-182980000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-132000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-67225000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,6700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,41179000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,41179000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,35041000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,18409000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,248771000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-199665000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,143735000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,143735000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34595000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-60000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-721545000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1028735000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-183000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,212412000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,212412000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-155000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,124862000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-94100000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-124238000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-124238000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,214000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,232123000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,13512000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,2011-01-01,2011-12-31,2014-02-11 16:38:29+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-327354000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-327354000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,33522000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,15424000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,249349000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-496972000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-526031000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-526031000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39694000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-60000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-711278000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1242132000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-667000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,430493000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,430493000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-50000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,118189000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,68189000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,68189000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-27356000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,6812000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,228452000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,228452000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7750000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2669000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,145554000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-341530000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,42895000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,42895000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9985000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-115980000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,147611000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-200000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21446000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21446000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20069000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20069000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20069000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-60000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,84350000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-146962000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-146962000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,25317000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,11856000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,217315000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-467454000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-359928000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-359928000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25266000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-60000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-251089000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,937117000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-574000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,600188000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,600188000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-50000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,108742000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,58742000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,58742000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,346000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,299348000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 16:32:20+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,6812000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-764763000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-764763000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32530000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,16206000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,134650000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-151539000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-732916000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-732916000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-40539000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-60000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1048576000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1556171000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-423000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,406633000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,406633000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-50000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,391645000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,104970000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,446571000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,446615000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,255000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,120587000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,6812000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-199318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-199318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8709000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2582000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,36803000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-64971000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-216195000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-216195000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10431000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-60000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10113000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,253144000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,190000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,172790000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,172790000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,55030000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,55030000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,55030000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,34000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11659000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,6812000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-375414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-375414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17567000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9187000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,71761000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-125924000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-402823000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-402823000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15281000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-60000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-135109000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,789506000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-374000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,578742000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,578742000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-50000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,88673000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,38673000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,38673000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,406000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,214998000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-08 16:31:41+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,6812000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-765451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-765451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,31733000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,16963000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,151615000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-60468000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-625608000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-625608000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39794000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1317693000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1636894000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4916000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,274491000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,274491000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-49978000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,391667000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,59413000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,401058000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,401058000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,48000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,49989000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-176096000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-176096000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8858000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6605000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,34958000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-60953000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-186628000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-186628000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4850000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-124996000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,536362000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-564000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,405952000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,405952000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-50000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,33643000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-16357000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-16357000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,372000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:17:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,203339000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78076000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78076000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12373000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,84624000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,21638000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,40559000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,40559000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28046000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-391815000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,426613000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,404000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7156000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7156000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12808000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16771000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,874000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4837000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4837000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-31000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,52521000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,6700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51135000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51135000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,38191000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,255942000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,24843000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,267841000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,267841000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-71140000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1723934000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1367927000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1330000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-425817000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-425817000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-21488000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,191721000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1971000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,172204000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,172204000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-141000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14087000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,13400000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 16:23:20+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,215082000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,215082000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,35542000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6553000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,202774000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,270994000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,730945000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,730945000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-52423000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1802575000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1032932000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1317000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-820749000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-820749000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-113680000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,191070000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-93003000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-15613000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-15613000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-242000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-105659000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,13400000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26467000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26467000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8593000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,29866000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,93969000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,105961000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,105961000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21396000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-550369000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,439126000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1411000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-131228000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-131228000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8680000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16947000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-117000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8150000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8150000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-58000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17175000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,26941000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26941000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,25818000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,171318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3205000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,227282000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,227282000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-43094000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1332119000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,941314000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,926000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-432973000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-432973000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8680000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,174950000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1097000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,167367000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,167367000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-110000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-38434000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:22:30+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,6700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,470001000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,470001000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34699000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9222000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,318462000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-164505000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,667879000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,667879000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41012000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1368186000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,741417000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-294000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-668075000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-668075000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-105000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,194192000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-92886000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3694000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3694000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-244000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4134000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,13400000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34468000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34468000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8665000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,111681000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,32527000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,118405000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,118405000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15543000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-372432000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,318201000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-269000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-70043000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-70043000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,136705000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,987000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,137692000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,137692000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,84000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,186138000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,6700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,53408000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,53408000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17225000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,141452000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-90764000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,121321000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,121321000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21698000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-781750000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,502188000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-485000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-301745000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-301745000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,158003000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1214000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,159217000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,159217000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-52000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21259000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-02 16:02:47+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,6700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,305151000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,305151000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34743000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,11804000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,243584000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-262003000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,333279000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,333279000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35900000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-60000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1005867000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,676360000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,165000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-425242000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-425242000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-105000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,112517000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-93873000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-86356000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-86356000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-294000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-178613000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,13512000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,87876000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,87876000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8560000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,29771000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-123291000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2916000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2916000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6155000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-409318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,183987000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-216000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-231702000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-231702000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,21298000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,227000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,21525000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,21525000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-136000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-207397000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:33:48+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-687550000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-687550000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,48365000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,877761000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-299200000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-60624000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-60666000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-51393000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2412418000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2376179000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-24929000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-112561000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-112561000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-16215000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,265878000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1252000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,248411000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,248411000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4708000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,79892000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,13458000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 16:23:48+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2840000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-478882000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-478882000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,42211000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,618410000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-101924000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,79815000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,79815000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-67850000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1840890000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1708340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,34041000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-166359000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-166359000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-78007000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,241590000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,757000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,164340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,164340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-610000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,77186000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,13842000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61712000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61712000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10554000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,58288000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8057000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-927000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-927000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1801000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-439735000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,405091000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,31754000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4691000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4691000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-28714000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,186202000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,157488000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,157488000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,278000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,152148000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,6899000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,2013-04-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-1541000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-374339000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-374339000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21245000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,503920000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-217531000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-66705000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-66705000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18408000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-898706000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,842601000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,32226000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-42287000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-42287000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-56519000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,207872000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,151353000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,151353000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-521000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,41840000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,7142000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-07-31 17:08:30+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-451638000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-451638000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,40322000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,671803000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-61340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,199147000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,199147000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-81592000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1773587000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1621450000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2018000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-231711000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-231711000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-49293000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,192093000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1744000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,144544000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,144544000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-804000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,111176000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,13643000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10859000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-312627000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-312627000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10691000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,445632000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-209474000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-65778000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-65778000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16607000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-458971000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,437510000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,472000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37596000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37596000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-27805000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,21670000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6135000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6135000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-799000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-110308000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,243000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:07:48+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1541000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-742745000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-742745000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,63257000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,177071000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-70695000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-573112000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-573112000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-51201000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-10000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1424172000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1559576000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,7806000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,82009000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,82009000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-21443000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,294243000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,274615000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1824000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,549239000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,549239000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2176000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,55960000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,68963000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,2014-01-01,2014-12-31,2017-02-23 15:18:18+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1210000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-180846000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-180846000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16336000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,40926000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-58199000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-181783000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-181783000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14676000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-10000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-357400000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,356176000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,7889000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18011000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18011000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,41210000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-8190000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,73341000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1824000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,108185000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,108185000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1695000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-93304000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,66146000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,412000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-561899000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-561899000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,46921000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,136145000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12496000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-391329000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-391329000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-36525000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1066772000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1203400000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-83000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,100020000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,100020000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-62653000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,302433000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,201274000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,441054000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,441054000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-481000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,149264000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2817000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-30 16:23:50+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,798000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-170060000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-170060000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16961000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,47099000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18353000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-87647000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-87647000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9298000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-362795000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,402194000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,444000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30545000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30545000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-20477000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,294383000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,83327000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,357233000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,357233000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2126000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,298005000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-29116000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-391839000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-391839000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29960000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,89046000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-30849000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-303682000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-303682000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27227000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-703977000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,801206000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-527000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,69475000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,69475000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-42176000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8050000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,117947000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,83821000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,83821000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1645000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-148741000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,31933000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:16:59+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,798000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-705050000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-705050000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,57080000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,462887000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-112518000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-297601000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-297643000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-60212000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2217689000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2334784000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-57682000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-799000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-799000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1872000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8050000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,175953000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1252000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,180879000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,180879000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6874000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-110689000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,38249000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3638000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-159382000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-159382000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14172000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,42639000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-25349000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-127920000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-127920000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11701000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-323028000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,424662000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-51000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,89882000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,89882000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-24408000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,57813000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,33405000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,33405000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1146000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3487000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,15963000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,2014-04-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,658000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-232457000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-232457000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15788000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,46407000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5500000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-175762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-175762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15526000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-380949000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,376544000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-476000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20407000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20407000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-17768000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8050000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,60134000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,50416000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,50416000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,499000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-145254000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,15970000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,2014-01-01,2014-03-31,2015-05-04 16:29:38+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,140000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-607380000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-607380000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,53462000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,478536000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-95226000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-170608000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-170650000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50312000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2334396000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2315213000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-25877000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-95372000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-95372000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6178000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8050000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,304342000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1252000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,304962000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,304962000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,44946000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,29185000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1439000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-588181000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-588181000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,62343000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,243073000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-82667000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-365432000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-365432000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-45302000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-80000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-633041000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1079128000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-51929000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,268856000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,268856000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-19954000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,23662000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,185592000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-381000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,188919000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,188919000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2834000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,89509000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,85613000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,2015-01-01,2015-12-31,2018-02-14 18:01:38+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1806000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74669000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74669000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15747000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,59570000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,28495000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,29143000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,29143000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12527000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-340906000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,259710000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-28967000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-122690000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-122690000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3158000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10276000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45903000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-381000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,52640000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,52640000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-575000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-41482000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,21382000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3067000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-513512000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-513512000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,46596000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,183503000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-111162000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-394575000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-394575000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-32775000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-80000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-292135000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,819418000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-22962000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,391546000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,391546000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-16796000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,13386000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,139689000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,136279000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,136279000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2259000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,130991000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,64231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-31 16:48:15+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-1261000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-694358000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-694358000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,62932000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,224429000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-169361000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-576358000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-576358000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-47451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-90000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-649535000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1175594000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-15073000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,373535000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,373535000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,24414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5196000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,213030000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1824000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,244464000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,244464000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3954000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,37687000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,130377000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-849000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-93816000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-93816000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16168000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,56813000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-41238000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-62073000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-62073000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8797000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-166480000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75416000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1074000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-100935000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-100935000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2171000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,51839000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,49668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,49668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-953000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-114293000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,21346000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-2283000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-419696000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-419696000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30428000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,126690000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-69924000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-332502000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-332502000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23978000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-80000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-125655000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,744002000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-21888000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,492481000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,492481000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-14625000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,13386000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,87850000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,86611000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,86611000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1306000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,245284000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,42885000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-01 16:51:11+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1022000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-770602000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-770602000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,63725000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,214715000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-109770000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-601932000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-601932000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-47952000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-90000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-845850000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1502372000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-13555000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,505015000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,505015000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,6108000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,299579000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,244518000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1824000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,552029000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,552029000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5127000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,449985000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,79915000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1434000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-220992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-220992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14065000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,68677000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,27984000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-110266000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-110266000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13420000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-80000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,372579000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-716000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,278443000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,278443000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-10037000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,46234000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,36197000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,36197000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1290000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,205664000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,21347000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,962000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-708992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-708992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,63832000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,188677000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-163103000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-619586000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-619586000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-46233000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-10000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1168878000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1554455000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-12890000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,316454000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,316454000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8263000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,299579000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,256097000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1824000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,549237000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,549237000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5271000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,240834000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,74531000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1130000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-198704000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-198704000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16363000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,58013000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-97908000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-222236000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-222236000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10558000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-125655000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,371423000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-21172000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,214038000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,214038000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4588000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,13386000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,41616000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,50414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,50414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2596000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39620000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,21538000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:03:32+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,60000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-84031000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-84031000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,61398000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,320179000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-61443000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,236103000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,236103000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-56563000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-616625000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,757562000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-33136000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,51238000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,51238000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-95700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,86173000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,68230000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,74568000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,133271000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,133271000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4666000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,415946000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,83656000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 16:38:26+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-2579000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,27759000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27759000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,142460000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-40946000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,144724000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,144724000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14788000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,23075000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,201693000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-33043000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,176937000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,176937000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-82370000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,84143000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17065000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,74924000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,93762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,93762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4401000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,411022000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,18994000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-4196000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-111790000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-111790000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,45947000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,177719000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20497000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,91379000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,91379000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41775000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-639700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,555869000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-93000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-125699000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-125699000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-13330000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2030000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,51165000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-356000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,39509000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,39509000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-265000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4924000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,64662000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-30 17:15:07+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1617000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-186459000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-186459000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,61694000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,237289000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7998000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,120522000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,120522000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-54302000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-980606000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,815579000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-29060000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-248389000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-248389000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-16488000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12306000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,97068000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-737000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,92149000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,92149000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-840000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-36558000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,86044000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4684000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39537000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39537000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14569000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,56869000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,33755000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,65656000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,65656000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13883000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-169623000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,215156000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3141000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,34791000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,34791000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5583000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2030000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17463000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-356000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13554000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13554000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-175000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,113826000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,23337000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,380000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72253000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72253000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,31378000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,120850000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-54252000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,25723000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,25723000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27892000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-470077000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,340713000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3234000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-160490000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-160490000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7747000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,33702000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,25955000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,25955000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-90000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-108902000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,41325000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:23:20+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1237000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-240738000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-240738000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,63293000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,237233000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-66995000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7207000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7207000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-49216000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-977463000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,675839000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-33275000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-384115000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-384115000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-13076000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10276000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,131444000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-381000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,128263000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,128263000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1618000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-264677000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,84053000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2021000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36151000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36151000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14963000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,69213000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7165000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,40860000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,40860000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15918000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-245453000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,206903000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3314000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57782000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57782000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3603000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,24856000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,21253000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,21253000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2710000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1621000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,20722000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,656000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36102000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36102000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16415000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,51637000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-47087000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15137000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15137000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11974000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-224624000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,133810000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,80000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-102708000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-102708000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4144000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8846000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4702000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4702000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2620000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-110523000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,20603000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:22:12+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,581000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-425579000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-425579000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,62395000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,236697000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-31846000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-158333000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-158333000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-46718000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-80000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-732010000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,841515000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-30677000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-47890000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-47890000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-19510000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10276000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,152822000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-381000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,143207000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,143207000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2382000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-60634000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,84678000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2327000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,91635000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,91635000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,61397000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,799659000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-107749000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,844942000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,844942000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-99421000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-160000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-594183000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,369214000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1061000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-483329000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-483329000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-300000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,344840000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,23564000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,68404000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,68404000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,5802000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,435819000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,68696000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,2017-01-01,2017-12-31,2020-02-13 16:48:57+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,102185000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,102185000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16432000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,82388000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,26506000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,227511000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,227511000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42984000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100928000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,122065000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1061000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20786000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20786000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,14188000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-4700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,46635000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17108000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,73231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,73231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,801000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,280757000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,16706000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2260000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10550000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10550000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,44965000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,717271000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-134255000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,617431000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,617431000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-56437000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-160000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-493255000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,247149000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-462543000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-462543000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-314188000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,298205000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6456000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4827000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4827000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,5001000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,155062000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,51990000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 16:10:19+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4154000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,17209000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17209000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,60416000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,859731000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-175201000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,762155000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,762155000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-71225000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-160000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-470180000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,448842000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-33043000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-285606000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-285606000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-396558000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,88843000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,315270000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,81380000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,88935000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,88935000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4401000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,5001000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,566084000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,70984000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-42000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-291267000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-291267000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15225000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,568146000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-122018000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,170086000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,170086000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27960000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-160000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-115588000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,78267000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-225281000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-225281000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3313000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,150318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,152705000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,152705000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,1501000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,99011000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,16987000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1936000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,280717000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,280717000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29740000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,149125000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12237000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,447345000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,447345000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28477000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-377667000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,168882000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-237262000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-237262000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-310875000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,147887000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5456000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-157532000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-157532000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,3500000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,56051000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,35003000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-26 16:08:10+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2218000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,268939000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,268939000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,59760000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,348454000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19428000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,657725000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,657725000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-57148000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-524215000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,585731000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-29902000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-25534000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-25534000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-398828000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,86173000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,182415000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,80024000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-50216000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-50216000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4576000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,3500000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,580899000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,77334000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-1598000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,31169000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31169000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14890000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,79105000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,56489000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,181653000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,181653000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17378000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-129394000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,70489000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-76283000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-76283000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6055000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,136638000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1450000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,132033000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,132033000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,2112000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,239515000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,17476000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1054000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,249548000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,249548000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14850000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,70020000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-68726000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,265692000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,265692000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11099000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-248273000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,98393000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-160979000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-160979000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-304820000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11249000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-289565000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-289565000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,1388000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-183464000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,17527000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:36:36+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1164000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,201619000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,201619000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,59833000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,338562000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-83082000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,516932000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,516932000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-55688000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-640274000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,722145000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-33216000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7033000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7033000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-396376000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,86173000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,70633000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,78574000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-160996000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-160996000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7286000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,1388000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,343005000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,80580000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-1996000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2087103000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2087103000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,72420000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,385068000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1274305000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1270286000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1270286000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-95524000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-439814000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,431576000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-98396000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-202158000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-202158000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-394000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-350043000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,289293000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10075000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-71219000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-71219000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-6182000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,990727000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,66458000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,2018-01-01,2018-12-31,2020-02-13 16:48:57+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12402000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1525096000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1525096000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18826000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,203391000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1432735000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,314578000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,314578000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15721000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49957000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,123170000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-98396000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-40904000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-40904000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,25264000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-143005000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-12983000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,43539000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-13861000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-101046000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-101046000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-1426000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,171202000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,16441000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2086000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,562007000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,562007000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,53594000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,181677000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,158430000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,955708000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,955708000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-79803000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-389857000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,308406000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-161254000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-161254000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-25658000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-207038000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12983000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,245754000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3786000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,29827000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,29827000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-4756000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,819525000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,50017000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:19:23+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10316000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,664192000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,664192000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,70026000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,264065000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,184936000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1183219000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1183219000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-122787000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-490785000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,430471000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1061000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-182040000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-182040000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11470000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-207038000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8283000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,292389000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20894000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,103058000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,103058000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-3955000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1100282000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,66723000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12576000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,128456000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,128456000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19192000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,153539000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,80161000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,381348000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,381348000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20912000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-166355000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,137378000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49889000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49889000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11448000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-92005000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3417000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,100917000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1198000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2079000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2079000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-555000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,332983000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,16573000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3247000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,433551000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,433551000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34402000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28138000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,78269000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,574360000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,574360000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58891000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-223502000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,171028000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-111365000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-111365000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-14210000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-115033000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9566000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,144837000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2588000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,27748000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,27748000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-4201000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,486542000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,33444000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-08-01 16:20:06+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7069000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,244469000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,244469000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,66059000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,678672000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17243000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,971957000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,971957000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-129835000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-160000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-440018000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,371360000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1061000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-357432000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-357432000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3335000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-115033000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9566000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,341790000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20696000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,253684000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,253684000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-1899000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,866310000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,67137000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,11265000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,206250000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,206250000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18059000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2802000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,100196000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,321703000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,321703000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29612000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-163349000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,76663000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-116298000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-116298000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3879000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-105033000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,56434000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1270000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-51208000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-51208000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-5857000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,148340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,16619000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5172000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,227301000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,227301000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16343000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,30940000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-21927000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,252657000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,252657000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29279000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60153000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,94365000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4933000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4933000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-10331000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9566000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,88403000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,78956000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,78956000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,1656000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,338202000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,16825000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:37:21+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1897000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,69388000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,69388000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,62890000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,760579000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-60950000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,831907000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,831907000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-117601000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-160000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-406063000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,365186000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1061000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-317417000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-317417000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5511000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9566000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,421994000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20876000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,436925000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,436925000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,6070000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,957485000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,67994000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7147000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,583234000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,583234000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,26256000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-16178000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-147304000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,446008000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,446008000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16761000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-908388000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-128238000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,195715000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-39319000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-896991000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-896991000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-819000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-36062000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1002000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,198614000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,690000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,161421000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,161421000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,5652000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-283910000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,13850000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1892000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1176810000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1176810000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,106941000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,179834000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,105745000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1569330000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1569330000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1154212000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-537196000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,570860000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-39319000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1235318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1235318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1951000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-192015000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,343244000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-22505000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,126773000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,126773000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,1643000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,462428000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,55554000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,2019-01-01,2019-12-31,2020-02-13 16:48:57+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,24730000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2118672000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2118672000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,99511000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,399403000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1179686000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1437900000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1437900000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-74411000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-245824000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-458915000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,498315000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-98396000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-379231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-379231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,24132000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-298958000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-11981000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,188169000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-37056000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-135694000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-135694000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-5435000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,917540000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,58145000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,24924000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,57518000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,57518000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,25847000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,106606000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,144818000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,334789000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,334789000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24291000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-245824000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-125322000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,146438000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-248999000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-248999000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1132000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-104000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,30538000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-8946000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20356000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20356000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-3201000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,102945000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,14595000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,11936000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,593576000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,593576000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,80685000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,196012000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,253049000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1123322000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1123322000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58690000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-245824000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-408958000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,375145000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-338327000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-338327000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1132000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-155953000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1002000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,144630000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-23195000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-34648000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-34648000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-4009000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,746338000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,41704000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:19:23+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,22838000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,536058000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,536058000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,54838000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,89406000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,108231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,788533000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,788533000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34399000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-283636000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,228707000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-89328000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-89328000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-155849000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1002000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,114092000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-14249000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-55004000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-55004000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-808000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,643393000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,27109000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-01 16:20:06+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10902000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2189610000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2189610000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,92856000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,446336000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1244343000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1484459000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1484459000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-71032000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-499948000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,489255000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-98396000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-180121000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-180121000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,13816000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-390859000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-8564000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,258548000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-26912000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-153971000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-153971000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-2789000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1147578000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,60123000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,16235000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,267427000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,267427000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,27698000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,41597000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,127027000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,463749000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,463749000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16358000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-155421000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,121589000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-50190000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-50190000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-61842000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1002000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,50472000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2647000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-13015000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-13015000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-430000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,400114000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,13961000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9067000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,268631000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,268631000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,27140000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,47809000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18796000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,324784000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,324784000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18041000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-128215000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,107118000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-39138000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-39138000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-94007000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,63620000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11602000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-41989000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-41989000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-378000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,243279000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,13148000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 16:37:49+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1835000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2128433000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2128433000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,83217000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,401937000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1271174000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1342413000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1342413000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-84286000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-507876000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,444329000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-98396000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-246229000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-246229000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,9937000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-434050000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-9566000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,264510000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-22995000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-192164000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-192164000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-8216000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,895804000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,62781000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1510932000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1510932000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,106622000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,302269000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,140421000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2060244000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2060244000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-76860000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1154212000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-490046000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,595923000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-39319000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1164514000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1164514000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1951000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-398034000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5833000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,359221000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-155737000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-190668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-190668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-4630000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,700432000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,56177000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,28740000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,602753000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,602753000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,26821000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,170244000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,15880000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,815698000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,815698000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-19450000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-81065000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,132181000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31666000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31666000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300026000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5833000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,79597000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-144834000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-359430000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-359430000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-6651000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,481283000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,13771000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,2020-01-01,2020-03-31,2020-05-01 16:37:49+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5845000.0
